Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 17;5(2):314-324.
doi: 10.1002/epi4.12399. eCollection 2020 Jun.

EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report

Affiliations

EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report

Aristea S Galanopoulou et al. Epilepsia Open. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Epilepsia Open. 2021 Jun;6(2):455. doi: 10.1002/epi4.12446. Epub 2020 Dec 25. Epilepsia Open. 2021. PMID: 34033705 Free PMC article. No abstract available.

Abstract

Objective: Acute encephalopathy may occur in COVID-19-infected patients. We investigated whether medically indicated EEGs performed in acutely ill patients under investigation (PUIs) for COVID-19 report epileptiform abnormalities and whether these are more prevalent in COVID-19 positive than negative patients.

Methods: In this retrospective case series, adult COVID-19 inpatient PUIs underwent EEGs for acute encephalopathy and/or seizure-like events. PUIs had 8-channel headband EEGs (Ceribell; 20 COVID-19 positive, 6 COVID-19 negative); 2 more COVID-19 patients had routine EEGs. Overall, 26 Ceribell EEGs, 4 routine and 7 continuous EEG studies were reviewed. EEGs were interpreted by board-certified clinical neurophysiologists (n = 16). EEG findings were correlated with demographic data, clinical presentation and history, and medication usage. Fisher's exact test was used.

Results: We included 28 COVID-19 PUIs (30-83 years old), of whom 22 tested positive (63.6% males) and 6 tested negative (33.3% male). The most common indications for EEG, among COVID-19-positive vs COVID-19-negative patients, respectively, were new onset encephalopathy (68.2% vs 33.3%) and seizure-like events (14/22, 63.6%; 2/6, 33.3%), even among patients without prior history of seizures (11/17, 64.7%; 2/6, 33.3%). Sporadic epileptiform discharges (EDs) were present in 40.9% of COVID-19-positive and 16.7% of COVID-19-negative patients; frontal sharp waves were reported in 8/9 (88.9%) of COVID-19-positive patients with EDs and in 1/1 of COVID-19-negative patient with EDs. No electrographic seizures were captured, but 19/22 COVID-19-positive and 6/6 COVID-19-negative patients were given antiseizure medications and/or sedatives before the EEG.

Significance: This is the first preliminary report of EDs in the EEG of acutely ill COVID-19-positive patients with encephalopathy or suspected clinical seizures. EDs are relatively common in this cohort and typically appear as frontal sharp waves. Further studies are needed to confirm these findings and evaluate the potential direct or indirect effects of COVID-19 on activating epileptic activity.

Keywords: COVID‐19; SARS‐CoV‐2; encephalopathy; epileptiform discharges; seizures.

PubMed Disclaimer

Conflict of interest statement

AS Galanopoulou is co‐Editor in Chief of Epilepsia Open and has received royalties for publications from Elsevier and Morgan & Claypool publishers. AD Legatt serves on the editorial board of Journal of Clinical Neurophysiology and has received royalties for a publication from Springer Publishing. He has received consultant’s fees from Brain Sentinel. SR Haut serves on the editorial board of Epilepsy and Behavior. SL Moshé is serving as Associate Editor of Neurobiology of Disease and is on the editorial board of Brain and Development, Pediatric Neurology and Physiological Research. He receives from Elsevier an annual compensation for his work as Associate Editor in Neurobiology of Disease and royalties from two books he co‐edited. He has received consultant's fees from UCB and Pfizer. AB Boro is site PI for clinical trials sponsored clinical trials sponsored by Biogen, SK Life Science, Neurelis and UCB. He receives no salary support or other reimbursement for these projects. All funds go to the institution. None of the other authors have conflicts to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Figures

FIGURE 1
FIGURE 1
Examples of frontal sharp waves or spikes in EEGs of COVID‐19‐positive patients and encephalopathy. (A,B) Examples of 8ch‐EEG from a 65 y old man with no prior history of epilepsy presenting with delirium (A) and a 77 y old woman with history of epilepsy presenting with an episode of confusion, reminiscent of her old seizures (B). The prior epilepsy classification is unknown for this patient whose prior medical care was outside our hospital network. EEGs demonstrate frontal sharp waves bilateral (A) or frontal spikes right more than left (B). High pass filter 1 Hz, low pass filter 30 Hz. (C) Routine EEG of a 61 y old man with no prior history of epilepsy, who presented with fever, respiratory failure requiring intubation who manifested “20 second intervals of bilateral arm jerking with eyes rolling back” and “myoclonic seizure activity at the face and left arm” after taken off propofol. His EEG showed right frontal sharp waves. High pass filter 1 Hz, low pass filter 70 Hz. Scale bars indicate sensitivity and timescale. Horizontal bars indicate the times when epileptic activities are seen. ECGR‐ECGL: electrocardiogram channel

Comment in

References

    1. Mao L, Wang M, Chen S, Hu Y, Chen S, He Q, et al. Neurological manifestations of hospitalized patients with COVID‐19 in Wuhan, China: a retrospective case series study. JAMA Neurol. 2020. in press. 10.1101/2020.02.22.20026500 - DOI - PMC - PubMed
    1. Chen T, Wu DI, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. - PMC - PubMed
    1. Li Y, Bai WZ, Hashikawa T. Response to Commentary on: "The neuroinvasive potential of SARS‐CoV‐2 may play a role in the respiratory failure of COVID‐19 patients". J Med Virol. 2020. in press. - PMC - PubMed
    1. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol. 2020. in press. - PMC - PubMed
    1. Zhou L, Zhang M, Wang J, Gao J. Sars‐Cov‐2: Underestimated damage to nervous system. Travel Med Infect Dis. 2020;101642. in press. - PMC - PubMed

LinkOut - more resources